Entero Healthcare Solutions IPO: Navigating New Investment Horizons

Navigating the IPO Landscape with Entero Healthcare Solutions

As an investor, stepping into the world of Initial Public Offerings (IPOs) can be both exciting and overwhelming. Entero Healthcare Solutions Limited, a key player in healthcare product distribution, is set to launch its IPO from February 9 to February 13, 2024. If you’re new to IPO investments, this beginner’s guide will walk you through the essentials of Entero Healthcare Solutions .

Entero Healthcare Solutions Limited, established in 2018, is gearing up for its IPO, aiming to raise Rs 1,600.00 crores. The IPO comprises a fresh issue of 0.79 crore shares amounting to Rs 1,000.00 crores and an offer for sale of 0.48 crore shares worth Rs 600.00 crores. With a tentative listing date of February 16, 2024, on both BSE and NSE this IPO opens doors for investors seeking.

IPO Dates: February 9, 2024, to February 13, 2024

Price Band: ₹1195 to ₹1258 per share

Lot Size: 11 shares

Total Issue Size: 12,718,600 shares, aggregating up to ₹1,600.00 Cr

Fresh Issue: 7,949,125 shares, aggregating up to ₹1,000.00 Cr

Offer for Sale: 4,769,475 shares, aggregating up to ₹600.00 Cr

Subscription and Allotment: The IPO subscription window opens on February 9, 2024, and closes on February 13, 2024. Allotment is expected to be finalized on February 14, 2024. Investors can bid for a minimum of 11 shares, and the minimum investment for retail investors is ₹13,838. The IPO will list on both BSE and NSE.

How to Open a Free Demat Account: Before diving into the Entero Healthcare Solutions IPO, it’s crucial to have a Demat account. A Demat account is a digital repository for holding and managing your securities electronically.

Financial Snapshot: Entero Healthcare Solutions, with relationships with over 1,900 healthcare product manufacturers, has experienced significant growth. Despite a negative profit after tax in recent years, the company’s robust revenue increase of 30.84% showcases its potential for future expansion.

Objectives of the Issue: The company intends to utilize the Net Proceeds from the Fresh Issue for purposes such as repayment/prepayment of certain borrowings, funding long-term working capital requirements, and pursuing inorganic growth initiatives through acquisitions.